Thalidomide 200 MG Oral Capsule [Thalomid] — RxCUI 404450
RxNorm drug concept · Semantic branded drug
RxCUI 404450
Semantic branded drug · SBD
● Current RxNorm concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI404450
Official nameThalidomide 200 MG Oral Capsule [Thalomid]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asThalomid 200 MG Oral Capsule
FDA products mapped4
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Thalidomide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Thalidomide has a deeply serious history — it caused thousands of severe birth defects in the 1950s and 60s when it was used without proper safeguards. Today it's only available th...
- Why is thalidomide so tightly controlled? I had to sign a bunch of forms just to get it.
- Yes, unfortunately you do. Thalidomide has been found in the semen of men who take it, which means it could potentially reach a pregnancy through sexual contact. You'll need to use...
- I'm a man — do I really need to worry about the pregnancy warnings too?
🕸️ Concept Web — How Thalidomide 200 MG Oral Capsule [Thalomid] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Thalidomide 200 MG Oral Capsule [Thalomid]
RxCUI 404450 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thalidomide
10432IN
-
Thalidomide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Thalomid
220239BN
-
Thalomid
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thalidomide Oral Capsule
374072SCDF -
Thalidomide Oral Product
1164873SCDG -
Thalidomide Pill
1164874SCDG -
Thalidomide Oral Capsule [Thalomid]
366451SBDF -
Thalomid Oral Product
1184929SBDG -
Thalomid Pill
1184930SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Thalidomide Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thalidomide 200 MG Oral Capsule
360177SCD -
Thalidomide 200 MG
360322SCDC -
Thalidomide 200 MG [Thalomid]
576407SBDC
-
Thalidomide 200 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thalidomide 200 MG Oral Capsule
SCD · 360177 -
Thalidomide 200 MG
SCDC · 360322 -
Thalidomide Oral Capsule
SCDF · 374072 -
Thalidomide Oral Product
SCDG · 1164873 -
Thalidomide Pill
SCDG · 1164874
Brand-Name Concepts
-
Thalidomide 200 MG [Thalomid]
SBDC · 576407 -
Thalidomide Oral Capsule [Thalomid]
SBDF · 366451 -
Thalomid Oral Product
SBDG · 1184929 -
Thalomid Pill
SBDG · 1184930 -
Thalomid
BN · 220239
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 404450 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59572-0205-94 | 10 BLISTER PACK in 1 BOX (59572-205-94) / 28 CAPSULE in 1 B... | Thalomid | Celgene Corporation | 2003-06-20 |
| 59572-0205-97 | 10 BLISTER PACK in 1 BOX (59572-205-97) / 1 CAPSULE in 1 BL... | Thalomid | Celgene Corporation | 2011-01-26 |
| 59572-0210-95 | 5 BLISTER PACK in 1 BOX (59572-210-95) / 28 CAPSULE in 1 BL... | Thalomid | Celgene Corporation | 2003-06-20 |
| 59572-0215-93 | 4 BLISTER PACK in 1 BOX (59572-215-93) / 28 CAPSULE in 1 BL... | Thalomid | Celgene Corporation | 2007-03-20 |
| 59572-0220-96 | 3 BLISTER PACK in 1 BOX (59572-220-96) / 28 CAPSULE in 1 BL... | Thalomid | Celgene Corporation | 2003-06-20 |
Observed labelers:
Celgene Corporation (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.